Qiming Venture Partners
Qiming Venture Partners (启明创投) is a China based venture capital firm. Founded in 2006, it is considered one of the largest and most active venture capital firms in China.[3][4] It invests in media, internet, information technology, consumer retail and healthcare sectors.[5] It is notable for investing in some of China's biggest technology companies.[6]
Type | Private |
---|---|
Industry | Venture Capital |
Founded | 2006 |
Headquarters | Shanghai, China |
Key people | Gary Rieschel Duane Kuang |
Products | Investments |
AUM | US $5.6 billion (2020)[1][2] |
Website | www.qimingvc.com |
Background
Founded in 2006, Qiming Venture Partners is a venture capital firm headquartered in Shanghai with offices in Beijing, Suzhou, Shenzhen and Hong Kong.[7]
It engages in early-stage ventures, late-stage ventures, post-IPO and private equity.[6]
In 2017, it set up its American entity, Qiming Venture Partners (USA) headquartered in Seattle, Washington with offices in Cambridge, Massachusetts and San Francisco, California.[8] This entity focuses investing in early-stage healthcare technology companies in the United States and Europe.[9]
As of 2020, Qiming Venture Partners manages in total, nine US Dollar funds and six RMB funds with $5.6 billion assets under management.[1][2]
Investments
As of October 2020, Qiming Venture Partners has invested in over 370 companies and has held over 40 IPOs and 80 other forms of investment exits.[1]
References
- "启明创投". www.qimingvc.com.
- "Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange". finance.yahoo.com. Retrieved 2021-01-22.
- "China Internet Report 2020" (PDF). July 2020.
- "China Venture Capital Private Equity Annual Ranking 2018" (PDF). Zero2IPO Group. 2018.
- "China venture capital deal-making shows green shoots of recovery as funds hunt for bargains among coronavirus hit start-ups". finance.yahoo.com. Retrieved 2021-01-23.
- "Qiming Venture Partners - Crunchbase Investor Profile & Investments". Crunchbase. Retrieved 2021-01-22.
- "Contact Us | Qiming Venture Partners". www.qimingvc.com. Retrieved 2021-01-22.
- "Contact". Qiming Venture Partners USA. Retrieved 2021-01-22.
- "Who We are". Qiming Venture Partners USA. Retrieved 2021-01-22.
- "ByteDance company information, funding & investors". app.dealroom.co. Retrieved 2021-01-22.
- "Series D - ByteDance - 2017-04-07 - Crunchbase Funding Round Profile". Crunchbase. Retrieved 2021-01-22.
- "Family offices back $1.1bn China healthcare and tech fund". Wealth Manager. Retrieved 2021-01-22.
- Partners, Qiming Venture. "Qiming congratulates Xiaomi on its successful IPO on the Hong Kong Stock Exchange". www.prnewswire.com. Retrieved 2021-01-22.
- Fannin, Rebecca. "Qiming Piles on 5th Fund At $650M for More Deals Like Xiaomi | Silicon Dragon Ventures". Retrieved 2021-01-23.
- "Query Builder | Investors | Crunchbase". Crunchbase. Retrieved 2021-01-22.
- "Series B - Bilibili - 2015-01-14 - Crunchbase Funding Round Profile". Crunchbase. Retrieved 2021-01-22.
- "Baidu pumps money into Zhihu". SHINE. Retrieved 2021-01-22.
- "Qiming Venture Partners boosts 7th fund to $1.2B, battling back against COVID-19 headwinds". FierceBiotech. Retrieved 2021-01-22.
- "Schrödinger Just Raised $85M and is Disrupting the Biopharma Industry with Technology". AlleyWatch. 2019-01-22. Retrieved 2021-01-22.
- "Series A - UBTech Robotics - 2015-12-01 - Crunchbase Funding Round Profile". Crunchbase. Retrieved 2021-01-22.
- "Insilico signs $200M AI drug discovery partnership with China's CTFH". FierceBiotech. Retrieved 2021-01-22.
- Wang, Eudora (2019-08-26). "Alibaba-Backed Chinese AI Unicorn Megvii Eyes Hong Kong IPO". China Money Network. Retrieved 2021-01-22.
- Su, Wiki (2015-01-19). "Chengwei, SIG, Qiming Participate $100M Series B In Apus". China Money Network. Retrieved 2021-01-22.
- Pradhan, Dipen (2019-07-29). "This Hospitality Startup wants to Become a Mix of Uber & Marriott of Southeast Asia". Entrepreneur. Retrieved 2021-01-22.
External links
- www.qimingvc.com (Company Website)